These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10920275)

  • 41. Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production.
    Colucci R; Blandizzi C; Tanini M; Vassalle C; Breschi MC; Del Tacca M
    Br J Pharmacol; 2005 Feb; 144(3):338-48. PubMed ID: 15655524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bile acid induces cyclo-oxygenase-2 expression in cultured human pharyngeal cells: a possible mechanism of carcinogenesis in the upper aerodigestive tract by laryngopharyngeal reflux.
    Sung MW; Roh JL; Park BJ; Park SW; Kwon TK; Lee SJ; Kim KH
    Laryngoscope; 2003 Jun; 113(6):1059-63. PubMed ID: 12782823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of cyclooxygenase-2 activity enhances steroidogenesis and steroidogenic acute regulatory gene expression in MA-10 mouse Leydig cells.
    Wang X; Dyson MT; Jo Y; Stocco DM
    Endocrinology; 2003 Aug; 144(8):3368-75. PubMed ID: 12865315
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2.
    Wang SC; Lien HC; Xia W; Chen IF; Lo HW; Wang Z; Ali-Seyed M; Lee DF; Bartholomeusz G; Ou-Yang F; Giri DK; Hung MC
    Cancer Cell; 2004 Sep; 6(3):251-61. PubMed ID: 15380516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
    Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
    Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells.
    van Zanden JJ; Geraets L; Wortelboer HM; van Bladeren PJ; Rietjens IM; Cnubben NH
    Biochem Pharmacol; 2004 Apr; 67(8):1607-17. PubMed ID: 15041478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptional silencing of Cyclooxygenase-2 by hyper-methylation of the 5' CpG island in human gastric carcinoma cells.
    Song SH; Jong HS; Choi HH; Inoue H; Tanabe T; Kim NK; Bang YJ
    Cancer Res; 2001 Jun; 61(11):4628-35. PubMed ID: 11389100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinoma.
    Wesseling JG; Yamamoto M; Adachi Y; Bosma PJ; van Wijland M; Blackwell JL; Li H; Reynolds PN; Dmitriev I; Vickers SM; Huibregtse K; Curiel DT
    Cancer Gene Ther; 2001 Dec; 8(12):990-6. PubMed ID: 11781662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
    Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells.
    Tang X; Sun YJ; Half E; Kuo MT; Sinicrope F
    Cancer Res; 2002 Sep; 62(17):4903-8. PubMed ID: 12208739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protection by quercetin against cooking oil fumes-induced DNA damage in human lung adenocarcinoma CL-3 cells: role of COX-2.
    Lin SY; Tsai SJ; Wang LH; Wu MF; Lee H
    Nutr Cancer; 2002; 44(1):95-101. PubMed ID: 12672646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially.
    Ciolino HP; Daschner PJ; Yeh GC
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):715-22. PubMed ID: 10359656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, and structure-activity relationship studies of 3,4,6-triphenylpyran-2-ones as selective cyclooxygenase-2 inhibitors.
    Rao PN; Uddin MJ; Knaus EE
    J Med Chem; 2004 Jul; 47(16):3972-90. PubMed ID: 15267236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcriptional regulation of the cyclooxygenase-2 gene changes from protein kinase (PK) A- to PKC-dependence after luteinization of granulosa cells.
    Wu YL; Wiltbank MC
    Biol Reprod; 2002 May; 66(5):1505-14. PubMed ID: 11967217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effects of caffeic acid phenethyl ester on the activity and expression of cyclooxygenase-2 in human oral epithelial cells and in a rat model of inflammation.
    Michaluart P; Masferrer JL; Carothers AM; Subbaramaiah K; Zweifel BS; Koboldt C; Mestre JR; Grunberger D; Sacks PG; Tanabe T; Dannenberg AJ
    Cancer Res; 1999 May; 59(10):2347-52. PubMed ID: 10344742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative effects of flavonoids on the growth, viability and metabolism of a colonic adenocarcinoma cell line (HT29 cells).
    Agullo G; Gamet-Payrastre L; Fernandez Y; Anciaux N; Demigné C; Rémésy C
    Cancer Lett; 1996 Jul; 105(1):61-70. PubMed ID: 8689634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flavonoids as Antidiabetic and Anti-Inflammatory Agents: A Review on Structural Activity Relationship-Based Studies and Meta-Analysis.
    Shamsudin NF; Ahmed QU; Mahmood S; Shah SAA; Sarian MN; Khattak MMAK; Khatib A; Sabere ASM; Yusoff YM; Latip J
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anticancer and antibacterial flavonoids from the callus of
    Li Y; Kumar PS; Tan S; Huang C; Xiang Z; Qiu J; Tan X; Luo J; He M
    RSC Adv; 2022 Aug; 12(37):24130-24138. PubMed ID: 36128517
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Barreto Linhares LPM; Pereira BVN; Dantas MKG; Bezerra WMDS; Viana-Marques DA; de Lima LRA; Sette-de-Souza PH
    Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenolic content, antioxidant, cytotoxic and antiproliferative effects of fractions of
    Okafor JNC; Rautenbauch F; Meyer M; Le Roes-Hill M; Harris T; Jideani VA
    Heliyon; 2021 Nov; 7(11):e08397. PubMed ID: 34901488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.